A Safety Study Of A Monoclonal Antibody Against A5B1 Integrin In Solid Tumors
Clinical trial NCT00915278 · TERMINATED
Trial details
- NCT number
- NCT00915278
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-01
- Primary completion
- 2013-01-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.